TIMP-2 as a Predictor of Tumor Stage in Colorectal Cancer
Author Information
Author(s): P Ring, K Johansson, M Hoyhtya, K Rubin, G Lindmark
Primary Institution: Uppsala Biomedical Centre, University of Uppsala
Hypothesis
Can TIMP-2 and MMP expressions predict tumor stage and survival time in colorectal cancer?
Conclusion
TIMP-2 expression is valuable for distinguishing between localized and metastatic colorectal cancer but does not predict micrometastases in potentially curable patients.
Supporting Evidence
- Positive expression of TIMP-2 was found significantly more often in localized tumors than in tumors with metastases.
- Patterns of TIMP-2 expression correlated with longer survival time.
- A large number of MMP-9-positive macrophages correlated with poor tumor differentiation.
Takeaway
This study looked at a protein called TIMP-2 in cancer samples to see if it could help doctors tell how serious the cancer is. They found that TIMP-2 can show if the cancer is localized or spread, but it can't tell if someone will have tiny cancer spots that are hard to see.
Methodology
Immunohistochemical staining of frozen tumor sections from 212 patients was performed to assess TIMP-2 and MMP expressions.
Limitations
TIMP-2 expression could not predict which potentially cured patients would have micrometastases.
Participant Demographics
212 patients (122 women, 90 men) aged 40 to 92 years, median age 70 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website